【前列腺癌】「ClarityDX®」: 結合機器學習與生物臨床訊息的「前列腺癌」血液檢測

 【前列腺癌】「ClarityDX®」: 結合機器學習與生物臨床訊息的「血液」檢測，可產生侵襲性「前列腺癌」的風險評分

 文章出處  

The Malaysian Reserve 

 

 原文標題  

Nanostics Prostate Cancer Screening Test, ClarityDX Prostate®, becomes accessible to men in British Columbia, Saskatchewan, and Ontario 

 

 文章序號  

5730 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.